Loading ChartRhythms
Preparing market rhythm analysis...
Preparing market rhythm analysis...
Full Rhythm Report
ALL • Stock • Financials / Property & Casualty Insurance
Current Price
$223.74
-0.30%
Provider quote snapshot • As of 2026-10-02T20:00:00.000Z
Back to stock pageCross-Horizon Read
ALL's evidence points cautious across the available windows.
Generated 2026-10-05T10:40:00.000Z • Evidence cbd302cf
Price Data
A quote snapshot is available, but historical price data is not connected yet.
ChartRhythms displays a price chart only when real historical time-series data is available. No estimated or synthetic chart is shown.
0–3 days
Supporting articles
0
Opposing articles
0
Neutral articles
0
Confidence basis
Supporting evidence
No supporting articles were found in this window.
Opposing evidence
No opposing articles were found in this window.
Catalysts
No specific catalysts were identified in this window.
Risks
No specific risk mentions were identified in this window.
Next proof points
• Additional dated, company-specific coverage in the 0–3 days window.
Strengthens if
• Supporting evidence (0) grows relative to opposing evidence (0) in this window.
• No evidence is available for this window is resolved.
Weakens if
• Opposing evidence (0) grows relative to supporting evidence (0) in this window.
Sources in this window (0)
No sources are available for this window yet.
4–21 days
Supporting articles
0
Opposing articles
0
Neutral articles
0
Confidence basis
Supporting evidence
No supporting articles were found in this window.
Opposing evidence
No opposing articles were found in this window.
Catalysts
No specific catalysts were identified in this window.
Risks
No specific risk mentions were identified in this window.
Next proof points
22–90 days
The 22–90 days evidence set currently reads slightly bearish.
Supporting articles
3
Opposing articles
4
Neutral articles
8
Confidence basis
Supporting evidence
• How Strong Q2 2026 Earnings and Buybacks Will Impact Allstate (ALL) Investors
• Should Value Investors Buy Allstate (ALL) Stock?
• Are Wall Street Analysts Bullish on Allstate Stock?
Opposing evidence
• Argus Research Downgrades Allstate to Hold
Help improve this analysis
This feedback is saved locally for the MVP. Later, ChartRhythms can use this feedback to improve the strategy engine.
Important:
ChartRhythms provides source-based market summaries for research and informational purposes only. This is not financial advice and not a recommendation to buy, sell, or hold any security.
• Additional dated, company-specific coverage in the 4–21 days window.
Strengthens if
• Supporting evidence (0) grows relative to opposing evidence (0) in this window.
• No evidence is available for this window is resolved.
Weakens if
• Opposing evidence (0) grows relative to supporting evidence (0) in this window.
Sources in this window (0)
No sources are available for this window yet.
• Keefe, Bruyette & Woods Downgrades Allstate to Underperform, Lowers Price Target to $250
• Keefe, Bruyette & Woods Downgrades Allstate (ALL)
• Allstate CEO Tom Wilson urges investment in quantum computing
Catalysts
• Argus Research Downgrades Allstate to Hold
• Keefe, Bruyette & Woods Downgrades Allstate to Underperform, Lowers Price Target to $250
• Here Are Thursday’s Top Wall Street Analyst Research Calls: Alphabet, Analog Devices, Crown Castle, ebay, EPR Properties, Etsy, Merck & Co., Shopify, TJX Companies, and More
• Cigna downgraded, Humana upgraded: Wall Street's top analyst calls
• Keefe, Bruyette & Woods Downgrades Allstate (ALL)
Risks
• 1 S&P 500 Stock with Competitive Advantages and 2 Facing Challenges
• Street Calls of the Week
• Allstate’s Q2 Earnings Call: Our Top 5 Analyst Questions
Next proof points
• Continued coverage in the 22–90 days window confirming the current read.
Strengthens if
• Supporting evidence (3) grows relative to opposing evidence (4) in this window.
Weakens if
• Opposing evidence (4) grows relative to supporting evidence (3) in this window.
Showing 8 of 15 sources
Dividend Champion, Contender, And Challenger Highlights: Week August 23
SeekingAlpha • 2026-08-21 • Neutral
Open via Finnhub →Keefe, Bruyette & Woods Downgrades Allstate to Underperform, Lowers Price Target to $250
Benzinga • 2026-08-20 • Bearish
Open via Finnhub →Here Are Thursday’s Top Wall Street Analyst Research Calls: Alphabet, Analog Devices, Crown Castle, ebay, EPR Properties, Etsy, Merck & Co., Shopify, TJX Companies, and More
Yahoo • 2026-08-20 • Neutral
Open via Finnhub →This Allstate Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday
Benzinga • 2026-08-20 • Neutral
Open via Finnhub →Cigna downgraded, Humana upgraded: Wall Street's top analyst calls
Yahoo • 2026-08-20 • Mixed
Open via Finnhub →How Strong Q2 2026 Earnings and Buybacks Will Impact Allstate (ALL) Investors
Yahoo • 2026-08-19 • Bullish
Open via Finnhub →